Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary

Taro Pharmaceutical Industries

19/05/2021 22:57

* Taro Pharmaceutical Industries Ltd  TARO.N  reported a
quarterly adjusted loss of 78 cents​​ per share for the quarter
ended in March. The lone analyst forecast for the quarter was
for earnings of 92 cents per share.
* Revenue fell 15.2% to $148.34 million from a year ago; 
analysts expected $147.33 million. 
* Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was a loss of 78 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Taro Pharmaceutical Industries Ltd shares had fallen by 2.4%
this quarter and lost 2.0% so far this year.
* The company reported a quarterly loss of $29.79 million.
* Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $81.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 19 at 09:56 p.m. GMT.
​All figures in US dollars